Contents

1.

Head and neck cancers
   

2.

Screening tests for NPC - myth or reality

PET-CT Imaging in head and neck cancers

   

3.

IMRT - State of the art radiation technique for head and neck cancers

Management of pain in palliative care

   

4.

Nutrition for head and neck cancer patients

Speech therapy for communication and swallowing disorders

   

5.

Chemotherapy for nasopharyngeal carcinoma

Why and how to stop puffing and chewing tobacco?

   

6.

Oral premalignancies

Endoscopic fluorescence imaging to detect neoplasia in oral cavities

   

7.

Critical appraisal of medical literature
 

 

NCC Round Up

 

 

Staff Directory

 

 

Pharmacy Tips

 

 

Cancers of the head & neck- An Overview

 

 

Contact

   
   
 

www.singhealth.com.sg
Reg.No.:2000026982

We welcome your contributions
to Cancer Update. Send your
queries and comments to
Postgraduate Cancer Education
/Information Support Services,
National Cancer Centre, 11
Hospital Drive, Singapore 169610. Or phone us at
(65) 6236 9425, fax us at (65)
6536 5503, or email:
daalff@nccs.com.sg

Ask The Expert
Should you have questions on
cancer treatments, log onto
http://www.nccs.com.sg/ask
/index.htm

for more information.

Please note that contents are not to be quoted or repeated without the permission of the National Cancer Centre. All advice given
in Cancer Update is not intended to replace patient-doctor consultation.

   
   

 

 
Critical appraisal of medical literature - an application framework
 
 

In today’s context of clinical practice, we are faced with a barrage of clinical studies. Hardly a day goes by without an article in the media discussing exciting new findings from recently published clinical studies. But which of these studies are relevant and should these studies have any bearing on our clinical practice? Unfortunately, there are no hard and fast rules in critically appraising the medical literature. However, if we adhere to some simple guidelines, we conclude on the utility of a clinical study. Below is a suggested framework for evaluating clinical research studies. Bear in mind that this framework is not all-encompassing. However, with repeated application, it is a useful guide to determine the utility of clinical research outcomes.

Framework for evaluating a clinical research paper

Element of Paper Critical Issues
Title Does the title reflect:
-The study design?
-The primary hypothesis?
-The population under study?
The title should - reflect study objectives.
Research Question What is the primary hypothesis?
- On what basis was the research question conceived?
- Has the question been previously studied?
- Does it address the question it sets out to answer?
Study Design Generally should fit into two broad groups:
-Retrospective
   Case report
   Case series
   Case-control studies
-Prospective
   Cohort studies (non-interventional)
   Randomised controlled trial (interventional)
Study outcome(s) and appropriateness of outcome(s) to research question Primary Outcome
- Should be one main primary outcome
- Should be the most important and easily measured outcome
- Should be free from bias
- Should be appropriate to the research question
E.g. Death, survival, presence of disease, length of hospital stay, number of re-operations (all very objective parameters)

Secondary Outcomes
- Usually softer and more subjective end-points
- Usually added to the study to address secondary issuesE.g. Cost-effectiveness, pain, quality of life etc.
Study Population Look at the inclusion and exclusion criteria carefully:
-
Broad inclusion criteria means greater external validity but also means presence of confounding factors
-
Narrow inclusion criteria mean less confounding and an easily studied group but also means limited external validity
Check if the study population is appropriate to the study question at hand
Check if the study population is similar to your clinical practice population
Sample size considerations (especially in a clinical trial) Essential that sample size be calculated a priori before commencing any trial!Key components:
-
Type 1 error rate (significance level, p): Rejecting the null hypothesis when it should not be rejected. Usually 2-tailed and set at 95% i.e. < 5% chance that results obtained due to chance and results can be greater or lesser than expected difference
-
Power: Probability of determining significance in the study if a true difference exists. Reflection of Type 2 error rate i.e. failing to reject the null hypothesis when it should be (Power= 1 – type 2 error rate). Usually set at 80%
-
Difference in primary outcome between intervention and control groups: Usually gleaned from previously published or pilot studies. The larger the difference, the smaller the sample size required!
Type and appropriateness of statistical analysis
This requires some statistical knowledge. Information on data handling and analyses should be clearly stated. Be circumspect about analyses with multiple comparisons as the level of statistical significance may be influenced.Most tests should use a 2-tailed significance level set a 95% i.e. p<0.05. However, be wary if the analyses are disproportionate to the type and amount of data available.
Strengths and weaknesses of the paper Key questions:
- Was the study well conceived?
- Are all patients accounted for?
- Is there room for improvement?
- Any ethical concerns?
- Are the results well presented?
- Discussion relevant?
Should my clinical practice be altered? Key question:
Is there external validity?
- Efficacy vs effectiveness study
- Look at Table 1 – Demographics of patients, does your patient group resemble the study group
- Review the inclusion and exclusion criteria
- Search for confounders
- Any long term or safety data?
- Look for previously published studies examining similar issues
Does the study contribute to the existing body of literature? If the study is just one in a series of many similar studies but with slight variation in patient group or question, then it may be quite pointless!
The key questions:

- Is the study pioneering?
- Does it contribute to resolving a key issue in clinical practice?
- Will it influence clinical practice in the long and short run?
E.g. The Women’s Health Initiative study has influenced the practice of HRT use and has caused many clinicians to re-examine their practice and many patients to be more involved in their own care.

Dr Benjamin Chua
Visiting Specialist
Division of Clinical Trials and Epidemiologic Sciences